Icon

ZEMDRI (nda210303)- (EQ 500MG BASE/10ML (EQ 50MG BASE/ML))

PLAZOMICIN SULFATE CIPLA USA
EQ 500MG BASE/10ML (EQ 50MG BASE/ML)
No No
2031-Jun-02 2023-Jun-25
None None
2028-Jun-25 No
ZEMDRI is an aminoglycoside antibacterial indicated for the treatment of patients 18 years of age or older with Complicated Urinary Tract Infections (cUTI) including Pyelonephritis.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 500MG BASE/10ML (EQ 50MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.